Walleye Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Walleye Trading’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,000	Closed	-$235K	–	4805
2025 Q2	$235K	Sell	5,000 -48,323	-91%	-$2.15M	﹤0.01%	3140
2025 Q1	$2.35M	Buy	+53,323	New	+$2.45M	0.01%	1544
2024 Q2	–	Sell	-1,493	Closed	-$73.5K	–	4885
2024 Q1	$73.5K	Buy	+1,493	New	+$69K	﹤0.01%	3892
2023 Q4	–	Sell	-8,242	Closed	-$191K	–	5481
2023 Q3	$191K	Buy	+8,242	New	+$225K	﹤0.01%	3633

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Walleye Trading's SWTX Position: Q3 2025 in Review

Walleye Trading sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 5,000 shares — an estimated $235K sold.

Walleye Trading first reported a position in SWTX in Q3 2023 and held it in 4 quarters. The position peaked at $2.35M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Walleye Trading reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Walleye Trading sold 5,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $235K.
Walleye Trading first reported a position in SpringWorks Therapeutics in Q3 2023 and held it in 4 quarters.
Walleye Trading's SpringWorks Therapeutics position peaked at $2.35M in Q1 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.